ID

17258

Description

Health sector data set specifications from METeOR, Australia's repository for national metadata standards, developed by the Australian Institute of Health and Welfare (http://meteor.aihw.gov.au/content/index.phtml/itemId/345165) Acute coronary syndrome (clinical) DSS 2013-: The scope for the ACS data set specification is to collect data on the period between when a person with ACS symptoms was first referred to a hospital or directly presented at a hospital, and when a person leaves the hospital, either from the emergency department or is discharged from the hospital. Acute coronary syndrome pharmacotherapy data cluster: The pharmacotherapies collected in this data cluster are recommended for the management of acute coronary syndromes (ACS) in the national guidelines. The following pharmacotherapies are collected as part of this data cluster: · Aspirin · Angiotensin converting enzyme (ACE) inhibitor · Angiotensin II receptor blocker · Antithrombin · Beta-blocker · Clopidogrel · Fibrinolytic · Glycoprotein IIb/IIIa receptor antagonist · Statin The pharmacotherapy cluster collects information on the type of pharmacotherapies prescribed and the timing of each prescription.

Link

http://meteor.aihw.gov.au/content/index.phtml/itemId/345165

Keywords

Versions (1)
  1. 9/2/16 9/2/16 -
Uploaded on

September 2, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Acute coronary syndrome (clinical) DSS 2013- Acute coronary syndrome pharmacotherapy data cluster Metadata Online Registry (METeOR)

English

Acute coronary syndrome (clinical) DSS 2013- Acute coronary syndrome pharmacotherapy data cluster Metadata Online Registry (METeOR)

1 forms  
Person with acute coronary syndrome
Description

Person with acute coronary syndrome

Pharmacotherapy type prescribed for acute coronary syndrome in hospital
Description

Person with acute coronary syndrome—pharmacotherapy type prescribed in hospital, code N[N] Maximum occurences: 10 Identifying and definitional attributes Short name: Pharmacotherapy type prescribed for acute coronary syndrome in hospital Synonymous names: ACS pharmacotherapy type prescribed METeOR identifier: 344344 Registration status: Health, Standard 01/10/2008 Definition: The type of pharmacotherapy prescribed to a person in hospital for the treatment of acute coronary syndrome, as represented by a code. Data Element Concept: Person with acute coronary syndrome—pharmacotherapy type prescribed in hospital Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N[N] Maximum character length: 2 Permissible values: Value Meaning 1 Aspirin 2 Angiotensin converting enzyme (ACE) inhibitor 3 Angiotensin II receptor blocker 4 Antithrombin 5 Beta-blocker 6 Clopidogrel 7 Fibrinolytic 8 Glycoprotein IIb/IIIa receptor antagonist 9 Statin Supplementary values: 99 Not stated/inadequately described Collection and usage attributes Guide for use: CODE 1 Aspirin Includes: aspirin, astrix, cardiprin, cartia, aspro, disprin and solprin CODE 2 Angiotensin converting enzyme (ACE) inhibitor Includes: captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril and trandolapril CODE 3 Angiotensin II receptor blocker Includes: candesartan, eprosartan, irbesartan, losartin and temisartan CODE 4 Antithrombin Includes: dalteparin, danaparoid, enoxaparin, heparin, phenindione, warfarin, bivalirudin, fondaparinux, lepirudin CODE 5 Beta-blocker Includes: atenolol, bisoprolol, carvedilol, esmolol, labetolol, metoprolol, oxprenolol, pindolol, propranolol and sotalol CODE 6 Clopidogrel Includes: iscover and plavix CODE 7 Fibrinolytic Includes: streptokinase, tissue plasminogen activator (t-PA) (alteplase), reteplase (r-PA) and tenecteplase (TNK t-PA) CODE 8 Glycoprotein IIb/IIIa receptor Includes: abciximab, eptifibatide and tirofiban CODE 9 Statin Includes: atorvastatin, fluvastatin, pravastatin and simvastatin Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster DSS specific information: Codes provided for each of those prescribed during this hospital presentation. Data element attributes Collection and usage attributes Guide for use: A person may be prescribed one or more type of medication for acute coronary syndromes. Therefore more than one code may be recorded. Collection methods: This information should be recorded at the end of the person's hospital stay involving the treatment of acute coronary syndromes. Comments: The purpose of this data element is to collect information on the prescription of pharmacotherapy recommended for the treatment of acute coronary syndromes in the national guidelines. Additional information on the specific drug types prescribed is not required for this quality purpose. The health service may choose to collect additional information on the specific drug types prescribed within each of the core pharmacotherapies. Source and reference attributes Reference documents: National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand. Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006; 184; S1-S32. © MJA 2006 Relational attributes Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Pharmacotherapy type taken for acute coronary syndrome post discharge
Description

Person with acute coronary syndrome—pharmacotherapy type taken post discharge from hospital, code N[N] Maximum occurences: 7 Identifying and definitional attributes Short name: Pharmacotherapy type taken for acute coronary syndrome post discharge METeOR identifier: 344822 Registration status: Health, Standard 01/10/2008 Definition: The type of pharmacotherapy being taken by a person for the treatment of acute coronary syndrome following discharge from hospital, as represented by a code. Data Element Concept: Person with acute coronary syndrome—pharmacotherapy type taken post discharge from hospital Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N[N] Maximum character length: 2 Permissible values: Value Meaning 1 Aspirin 2 Angiotensin converting enzyme (ACE) inhibitor 3 Angiotensin II receptor blocker 4 Beta-blocker 5 Clopidogrel 6 Statin Supplementary values: 99 Not stated/inadequately described Collection and usage attributes Guide for use: CODE 1 Aspirin Includes: aspirin, astrix, cardiprin, cartia, aspro, disprin and solprin CODE 2 Angiotensin converting enzyme (ACE) inhibitor Includes: captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril and trandolapril CODE 3 Angiotensin II receptor blocker Includes: candesartan, eprosartan, irbesartan, losartin and temisartan CODE 4 Beta-blocker Includes: atenolol, bisoprolol, carvedilol, esmolol, labetolol, metoprolol, oxprenolol, pindolol, propranolol and sotalol CODE 5 Clopidogrel Includes: iscover and plavix CODE 6 Statin Includes: atorvastatin, fluvastatin, pravastatin and simvastatin Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster DSS specific information: To be provided at the follow-up visit following discharge from the hospital for each of the relevant pharmacotherapy types prescribed. Data element attributes Collection and usage attributes Guide for use: A person may be taking one or more type of medication for acute coronary syndromes (ACS). Therefore more than one code may be recorded. Collection methods: Following a person's hospital stay for ACS, follow-up consultations with a clinician may occur at various intervals, such as 3, 6 or 12 months after discharge from hospital. The medications being taken by the person at the time of each follow-up consultation should be recorded. Comments: The pharmacotherapies for the treatment of ACS that could be taken post discharge from hospital are different from the types that could be taken during the hospital stay as not all of the pharmacotherapies used for the treatment of ACS are for out of hospital use. Relational attributes Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Person
Description

Person

Fibrinolytic drug used
Description

Person—fibrinolytic drug administered, code N Obligation: Conditional Identifying and definitional attributes Short name: Fibrinolytic drug used METeOR identifier: 356870 Registration status: Health, Standard 01/10/2008 Definition: The type of fibrinolytic drug administered to a person, as represented by a code. Data Element Concept: Person—fibrinolytic drug administered Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N Maximum character length: 1 Permissible values: Value Meaning 1 Streptokinase 2 t-PA (Tissue Plasminogen Activator) (Alteplase) 3 r-PA (Reteplase) 4 TNK t-PA (Tenecteplase) Supplementary values: 9 Not stated/inadequately described Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide the fibrinolytic drug administered. Data element attributes Source and reference attributes Submitting organisation: Acute coronary syndrome data working group Relational attributes Related metadata references: Supersedes Person—fibrinolytic drug administered, code N Health, Superseded 01/10/2008 Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Date of intravenous fibrinolytic therapy
Description

Person—intravenous fibrinolytic therapy date, DDMMYYYY Obligation: Conditional Identifying and definitional attributes Short name: Date of intravenous fibrinolytic therapy METeOR identifier: 356921 Registration status: Health, Standard 01/10/2008 Definition: The date intravenous (IV) fibrinolytic therapy was first administered or initiated. Data Element Concept: Person—intravenous fibrinolytic therapy date Value domain attributes Representational attributes Representation class: Date Data type: Date/Time Format: DDMMYYYY Maximum character length: 8 Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide the date when the fibrinolytic therapy is administered. Data element attributes Collection and usage attributes Guide for use: If initiated by a bolus dose whether in a pre-hospital setting, emergency department or inpatient unit/ward, the date the initial bolus was administered should be recorded. Source and reference attributes Submitting organisation: Acute coronary syndrome data working group Relational attributes Related metadata references: Supersedes Person—intravenous fibrinolytic therapy date, DDMMYYYY Health, Superseded 01/10/2008 Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

date

Time of intravenous fibrinolytic therapy
Description

Person—intravenous fibrinolytic therapy time, hhmm Obligation: Conditional Identifying and definitional attributes Short name: Time of intravenous fibrinolytic therapy METeOR identifier: 360949 Registration status: Health, Standard 01/10/2008 Definition: The time intravenous (IV) fibrinolytic therapy was first administered to a person. Data Element Concept: Person—intravenous fibrinolytic therapy time Value domain attributes Representational attributes Representation class: Time Data type: Date/Time Format: hhmm Maximum character length: 4 Source and reference attributes Reference documents: ISO 8601:2000 : Data elements and interchange formats - Information interchange - Representation of dates and times Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide the time when the fibrinolytic therapy is administered. Data element attributes Collection and usage attributes Guide for use: If initiated by a bolus dose whether in a pre-hospital setting, emergency department or inpatient unit/ward, the time the initial bolus was administered should be recorded. Comments: This is used to calculate the time between initial presentation and reperfusion. Source and reference attributes Submitting organisation: Acute coronary syndrome data working group Relational attributes Related metadata references: Supersedes Person—intravenous fibrinolytic therapy time, hhmm Health, Superseded 01/10/2008 Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

time

Reason for non prescription of pharmacotherapy
Description

Person—reason for non prescription of pharmacotherapy, code N Obligation: Conditional, Maximum occurences: 9 Identifying and definitional attributes Short name: Reason for non prescription of pharmacotherapy METeOR identifier: 347222 Registration status: Health, Standard 01/10/2008 Definition: The reason a pharmacotherapy was not prescribed for a person, as represented by a code. Data Element Concept: Person—reason for non prescription of pharmacotherapy Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N Maximum character length: 1 Permissible values: Value Meaning 1 Not indicated 2 Contraindicated Supplementary values: 9 Not stated/inadequately described Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: To be provided for each of the pharmacotherapies listed in the data element 'Pharmacotherapy type prescribed for acute coronary syndrome in hospital' not prescribed. Data element attributes Collection and usage attributes Guide for use: CODE 1 Not indicated Record this code when a pharmacotherapy was not prescribed because it was not necessary to the treatment of the person. CODE 2 Contraindicated Record this code when a pharmacotherapy was not prescribed because of a condition or factor that increases the risks involved in using the pharmacotherapy. Examples of contraindications are allergy, intolerance, medical condition. Collection methods: For each type of pharmacotherapy not prescribed for the person, record whether it was not indicated or contraindicated. Relational attributes Related metadata references: See also Person with acute coronary syndrome—pharmacotherapy type prescribed in hospital, code N[N] Health, Standard 01/10/2008 Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Timing of ACE-inhibitor prescription
Description

Person—timing of ACE-inhibitor prescription, code N Obligation: Conditional, Maximum occurences: 5 Identifying and definitional attributes Short name: Timing of ACE-inhibitor prescription METeOR identifier: 349385 Registration status: Health, Standard 01/10/2008 Definition: The timing of care when an ACE-inhibitor is prescribed to a person, as represented by a code. Data Element Concept: Person—timing of ACE-inhibitor prescription Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N Maximum character length: 1 Permissible values: Value Meaning 1 Prior to presentation at hospital 2 First 24 hours of presentation 3 After 24 hours and before discharge 4 At discharge Supplementary values: 9 Not stated/inadequately described Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide a phase for each time ACE-inhibitor therapy is prescribed. Data element attributes Collection and usage attributes Guide for use: CODE 1 Prior to presentation at hospital Use this code when the person has been previously prescribed an ACE-inhibitor prior to presentation at the hospital and the person is still following the prescription. CODE 2 First 24 hours of presentation Use this code when an ACE-inhibitor is prescribed within the first 24 hours following presentation to the hospital. CODE 3 After 24 hours and before discharge Use this code when an ACE-inhibitor is prescribed following the first 24 hours after presentation to the hospital and before discharge from the hospital. CODE 4 At discharge Use this code when an ACE-inhibitor is prescribed at discharge from the hospital. Collection methods: Record each time an ACE-inhibitor is prescribed for the person. Relational attributes Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Timing of angiotensin II receptor blocker prescription
Description

Person—timing of angiotensin II receptor blocker prescription, code N Obligation: Conditional, Maximum occurences: 5 Identifying and definitional attributes Short name: Timing of angiotensin II receptor blocker prescription METeOR identifier: 350421 Registration status: Health, Standard 01/10/2008 Definition: The timing of care when an angiotensin II receptor blocker is prescribed to a person, as represented by a code. Data Element Concept: Person—timing of angiotensin II receptor blocker prescription Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N Maximum character length: 1 Permissible values: Value Meaning 1 Prior to presentation at hospital 2 First 24 hours of presentation 3 After 24 hours and before discharge 4 At discharge Supplementary values: 9 Not stated/inadequately described Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide a phase for each time angiotensin II receptor blocker therapy is prescribed. Data element attributes Collection and usage attributes Guide for use: CODE 1 Prior to presentation at hospital Use this code when the person has been previously prescribed an angiotensin II receptor blocker prior to presentation at the hospital and the person is still following the prescription. CODE 2 First 24 hours of presentation Use this code when an angiotensin II receptor blocker is prescribed within the first 24 hours following presentation to the hospital. CODE 3 After 24 hours and before discharge Use this code when an angiotensin II receptor blocker is prescribed following the first 24 hours after presentation to the hospital and before discharge from the hospital. CODE 4 At discharge Use this code when an angiotensin II receptor blocker is prescribed at discharge from the hospital. Collection methods: Record each time an angiotensin II receptor blocker is prescribed for the person. Relational attributes Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Timing of antithrombin therapy prescription
Description

Person—timing of antithrombin therapy prescription, code N Obligation: Conditional, Maximum occurences: 4 Identifying and definitional attributes Short name: Timing of antithrombin therapy prescription METeOR identifier: 350510 Registration status: Health, Standard 01/10/2008 Definition: The timing of care when antithrombin therapy is prescribed to a person, as represented by a code. Data Element Concept: Person—timing of antithrombin therapy prescription Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N Maximum character length: 1 Permissible values: Value Meaning 1 Initial medical management: preceding reperfusion therapy 2 During reperfusion therapy 3 Following reperfusion therapy Supplementary values: 9 Not stated/inadequately described Source and reference attributes Reference documents: National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand, Guidelines for the management of acute coronary syndromes 2006, Med J Aust; 184; S1-S32. © MJA2006. Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide a phase for each time antithrombin therapy is prescribed Data element attributes Collection and usage attributes Guide for use: Reperfusion therapy includes percutaneous coronary intervention and fibrinolytic therapy. CODE 1 Initial medical management: preceding reperfusion therapy Use this code when antithrombin therapy is prescribed before reperfusion therapy is to be performed. CODE 2 During reperfusion therapy Use this code when antithrombin therapy is prescribed while reperfusion therapy is being performed. CODE 3 Following reperfusion therapy Use this code when antithrombin therapy is prescribed after reperfusion therapy has been performed. Collection methods: Record for each time antithrombin therapy is prescribed for the person. Relational attributes Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Timing of aspirin prescription
Description

Person—timing of aspirin prescription, code N Obligation: Conditional, Maximum occurences: 5 Identifying and definitional attributes Short name: Timing of aspirin prescription METeOR identifier: 347829 Registration status: Health, Standard 01/10/2008 Definition: The timing of care when aspirin is prescribed to a person, as represented by a code. Data Element Concept: Person—timing of aspirin prescription Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N Maximum character length: 1 Permissible values: Value Meaning 1 Prior to presentation at hospital 2 First 24 hours of presentation 3 After 24 hours and before discharge 4 At discharge Supplementary values: 9 Not stated/inadequately described Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide a phase for each time aspirin therapy is prescribed. Data element attributes Collection and usage attributes Guide for use: CODE 1 Prior to presentation at hospital Use this code when the person has been previously prescribed aspirin prior to presentation at the hospital and the person is still following the prescription. CODE 2 First 24 hours of presentation Use this code when aspirin is prescribed within the first 24 hours following presentation to the hospital. CODE 3 After 24 hours and before discharge Use this code when aspirin is prescribed following the first 24 hours after presentation to the hospital and before discharge from the hospital. CODE 4 At discharge Use this code when aspirin is prescribed at discharge from the hospital. Collection methods: Record each time aspirin is prescribed for the person. Relational attributes Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Timing of beta-blocker prescription
Description

Person—timing of beta-blocker prescription, code N Obligation: Conditional, Maximum occurences: 5 Identifying and definitional attributes Short name: Timing of beta-blocker prescription METeOR identifier: 349400 Registration status: Health, Standard 01/10/2008 Definition: The timing of care when a beta-blocker is prescribed to a person, as represented by a code. Data Element Concept: Person—timing of beta-blocker prescription Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N Maximum character length: 1 Permissible values: Value Meaning 1 Prior to presentation at hospital 2 First 24 hours of presentation 3 After 24 hours and before discharge 4 At discharge Supplementary values: 9 Not stated/inadequately described Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide a phase for each time beta-blocker therapy is prescribed. Data element attributes Collection and usage attributes Guide for use: CODE 1 Prior to presentation at hospital Use this code when the person has been previously prescribed a beta-blocker prior to presentation at the hospital and the person is still following the prescription. CODE 2 First 24 hours of presentation Use this code when a beta-blocker is prescribed within the first 24 hours following presentation to the hospital. CODE 3 After 24 hours and before discharge Use this code when a beta-blocker is prescribed following the first 24 hours after presentation to the hospital and before discharge from the hospital. CODE 4 At discharge Use this code when a beta-blocker is prescribed at discharge from the hospital. Collection methods: Record each time a beta-blocker is prescribed for a person. Relational attributes Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Timing of clopidogrel prescription
Description

Person—timing of clopidogrel prescription, code N Obligation: Conditional, Maximum occurences: 5 Identifying and definitional attributes Short name: Timing of clopidogrel prescription METeOR identifier: 350431 Registration status: Health, Standard 01/10/2008 Definition: The timing of care when clopidogrel is prescribed to a person, as represented by a code. Data Element Concept: Person—timing of clopidogrel prescription Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N Maximum character length: 1 Permissible values: Value Meaning 1 Prior to presentation at hospital 2 First 24 hours of presentation 3 After 24 hours and before discharge 4 At discharge Supplementary values: 9 Not stated/inadequately described Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide a phase for each time clopidogrel therapy is prescribed. Data element attributes Collection and usage attributes Guide for use: CODE 1 Prior to presentation at hospital Use this code when the person has been previously prescribed clopidogrel prior to presentation at the hospital and the person is still following the prescription. CODE 2 First 24 hours of presentation Use this code when clopidogrel is prescribed within the first 24 hours following presentation to the hospital. CODE 3 After 24 hours and before discharge Use this code when clopidogrel is prescribed following the first 24 hours after presentation to the hospital and before discharge from the hospital. CODE 4 At discharge Use this code when clopidogrel is prescribed at discharge from the hospital. Collection methods: Record each time clopidogrel is prescribed for the person. Relational attributes Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Timing of glycoprotein IIb/IIIa inhibitor prescription
Description

Person—timing of glycoprotein IIb/IIIa inhibitor prescription, code N Obligation: Conditional, Maximum occurences: 4 Identifying and definitional attributes Short name: Timing of glycoprotein IIb/IIIa inhibitor prescription METeOR identifier: 349367 Registration status: Health, Standard 01/10/2008 Definition: The timing of care when a glycoprotein IIb/IIIa inhibitor is prescribed to a person, as represented by a code. Data Element Concept: Person—timing of glycoprotein IIb/IIIa inhibitor prescription Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N Maximum character length: 1 Permissible values: Value Meaning 1 Initial medical management: preceding invasive management 2 During invasive management 3 Following invasive management Supplementary values: 9 Not stated/inadequately described Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide a phase for each time glycoprotein IIb/IIIa inhibitor therapy is prescribed. Data element attributes Collection and usage attributes Guide for use: Invasive management includes angiography, percutaneous coronary intervention and coronary artery bypass graft. CODE 1 Initial medical management: preceding invasive management Use this code when a glycoprotein IIb/IIIa inhibitor is prescribed before invasive management is to be performed. CODE 2 During invasive management Use this code when a glycoprotein IIb/IIIa inhibitor is prescribed while invasive management is being performed. CODE 3 Following invasive management Use this code when a glycoprotein IIb/IIIa inhibitor is prescribed after invasive management has been performed. Collection methods: Record each time a glycoprotein IIb/IIIa inhibitor is prescribed for a person. Relational attributes Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Timing of statin prescription
Description

Person—timing of statin prescription, code N Obligation: Conditional, Maximum occurences: 5 Identifying and definitional attributes Short name: Timing of statin prescription METeOR identifier: 350445 Registration status: Health, Standard 01/10/2008 Definition: The timing of care when a statin is prescribed to a person, as represented by a code. Data Element Concept: Person—timing of statin prescription Value domain attributes Representational attributes Representation class: Code Data type: Number Format: N Maximum character length: 1 Permissible values: Value Meaning 1 Prior to presentation at hospital 2 First 24 hours of presentation 3 After 24 hours and before discharge 4 At discharge Supplementary values: 9 Not stated/inadequately described Data set specification specific attributes Acute coronary syndrome pharmacotherapy data cluster Conditional obligation: If prescribed, provide a phase for each time statin therapy is prescribed. Data element attributes Collection and usage attributes Guide for use: CODE 1 Prior to presentation at hospital Use this code when the person has been previously prescribed a statin prior to presentation at the hospital and the person is still following the prescription. CODE 2 First 24 hours of presentation Use this code when a statin is prescribed for within the first 24 hours following presentation to the hospital. CODE 3 After 24 hours and before discharge Use this code when an ACE-inhibitor is prescribed following the first 24 hours after presentation to the hospital and before discharge from the hospital. CODE 4 At discharge Use this code when a statin is prescribed at discharge from the hospital. Collection methods: Record each time a statin is prescribed for the person. Relational attributes Implementation in Data Set Specifications: Acute coronary syndrome pharmacotherapy data cluster Health, Standard 01/10/2008

Data type

integer

Back to the top of the page

Similar models

Acute coronary syndrome (clinical) DSS 2013- Acute coronary syndrome pharmacotherapy data cluster Metadata Online Registry (METeOR)

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Person with acute coronary syndrome
Item
Pharmacotherapy type prescribed for acute coronary syndrome in hospital
integer
Pharmacotherapy type in hospital
Code List
Pharmacotherapy type prescribed for acute coronary syndrome in hospital
CL Item
Aspirin (1)
CL Item
Angiotensin converting enzyme (ACE) inhibitor  (2)
CL Item
Angiotensin II receptor blocker  (3)
CL Item
Antithrombin  (4)
CL Item
Beta-blocker  (5)
CL Item
Clopidogrel (6)
CL Item
Fibrinolytic  (7)
CL Item
Glycoprotein IIb/IIIa receptor antagonist  (8)
CL Item
Statin (9)
CL Item
Not stated/inadequately described (99)
Item
Pharmacotherapy type taken for acute coronary syndrome post discharge
integer
Pharmacotherapy type taken post discharge from hospital
Code List
Pharmacotherapy type taken for acute coronary syndrome post discharge
CL Item
Aspirin (1)
CL Item
Angiotensin converting enzyme (ACE) inhibitor  (2)
CL Item
Angiotensin II receptor blocker  (3)
CL Item
Beta-blocker  (4)
CL Item
Clopidogrel (5)
CL Item
Statin (6)
CL Item
Not stated/inadequately described (99)
Item Group
Person
Item
Fibrinolytic drug used
integer
Fibrinolytic drug administered
Code List
Fibrinolytic drug used
CL Item
Streptokinase (1)
CL Item
t-PA (Tissue Plasminogen Activator) (Alteplase) (2)
CL Item
r-PA (Reteplase) (3)
CL Item
TNK t-PA (Tenecteplase) (4)
CL Item
Not stated/inadequately described (9)
Intravenous fibrinolytic therapy date
Item
Date of intravenous fibrinolytic therapy
date
Intravenous fibrinolytic therapy time
Item
Time of intravenous fibrinolytic therapy
time
Item
Reason for non prescription of pharmacotherapy
integer
Reason for non prescription of pharmacotherapy
Code List
Reason for non prescription of pharmacotherapy
CL Item
Not indicated (1)
CL Item
Contraindicated (2)
CL Item
Not stated/inadequately described (9)
Item
Timing of ACE-inhibitor prescription
integer
Timing of ACE-inhibitor prescription
Code List
Timing of ACE-inhibitor prescription
CL Item
Prior to presentation at hospital (1)
CL Item
First 24 hours of presentation (2)
CL Item
After 24 hours and before discharge (3)
CL Item
At discharge (4)
CL Item
Not stated/inadequately described (9)
Item
Timing of angiotensin II receptor blocker prescription
integer
Timing of angiotensin II receptor blocker prescription
Code List
Timing of angiotensin II receptor blocker prescription
CL Item
Prior to presentation at hospital (1)
CL Item
First 24 hours of presentation (2)
CL Item
After 24 hours and before discharge (3)
CL Item
At discharge (4)
CL Item
Not stated/inadequately described (9)
Item
Timing of antithrombin therapy prescription
integer
Timing of antithrombin therapy prescription
Code List
Timing of antithrombin therapy prescription
CL Item
Initial medical management: preceding reperfusion therapy (1)
CL Item
During reperfusion therapy (2)
CL Item
Following reperfusion therapy (3)
CL Item
Not stated/inadequately described (9)
Item
Timing of aspirin prescription
integer
Timing of aspirin prescription
Code List
Timing of aspirin prescription
CL Item
Prior to presentation at hospital (1)
CL Item
First 24 hours of presentation (2)
CL Item
After 24 hours and before discharge (3)
CL Item
At discharge (4)
CL Item
Not stated/inadequately described (9)
Item
Timing of beta-blocker prescription
integer
Timing of beta-blocker prescription
Code List
Timing of beta-blocker prescription
CL Item
Prior to presentation at hospital (1)
CL Item
First 24 hours of presentation (2)
CL Item
After 24 hours and before discharge (3)
CL Item
At discharge (4)
CL Item
Not stated/inadequately described (9)
Item
Timing of clopidogrel prescription
integer
Timing of clopidogrel prescription
Code List
Timing of clopidogrel prescription
CL Item
Prior to presentation at hospital (1)
CL Item
First 24 hours of presentation (2)
CL Item
After 24 hours and before discharge (3)
CL Item
At discharge (4)
CL Item
Not stated/inadequately described (9)
Item
Timing of glycoprotein IIb/IIIa inhibitor prescription
integer
Timing of glycoprotein IIb/IIIa inhibitor prescription
Code List
Timing of glycoprotein IIb/IIIa inhibitor prescription
CL Item
Initial medical management: preceding invasive management (1)
CL Item
During invasive management (2)
CL Item
Following invasive management (3)
CL Item
Not stated/inadequately described (9)
Item
Timing of statin prescription
integer
Timing of statin prescription
Code List
Timing of statin prescription
CL Item
Prior to presentation at hospital (1)
CL Item
First 24 hours of presentation (2)
CL Item
After 24 hours and before discharge (3)
CL Item
At discharge (4)
CL Item
Not stated/inadequately described (9)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial